These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 28601546)

  • 1. Influences of Obesity and Bariatric Surgery on the Clinical and Pharmacologic Profile of Rivaroxaban.
    Moore KT; Kröll D
    Am J Med; 2017 Sep; 130(9):1024-1032. PubMed ID: 28601546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of bariatric surgery on the direct oral anticoagulant rivaroxaban: the extension study.
    Kröll D; Nett PC; Borbély YM; Schädelin S; Bertaggia Calderara D; Alberio L; Stirnimann G
    Surg Obes Relat Dis; 2018 Dec; 14(12):1890-1896. PubMed ID: 30396779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rivaroxaban, a direct Factor Xa inhibitor, versus acetylsalicylic acid as thromboprophylaxis in children post-Fontan procedure: Rationale and design of a prospective, randomized trial (the UNIVERSE study).
    Pina LM; Dong X; Zhang L; Samtani MN; Michelson AD; Justino H; Bonnet D; Harris KC; Jefferies J; McCrindle BW; Li JS
    Am Heart J; 2019 Jul; 213():97-104. PubMed ID: 31132584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can an anti-Xa assay for low-molecular-weight heparin be used to assess the presence of rivaroxaban?
    Yates SG; Smith S; Tharpe W; Shen YM; Sarode R
    Transfus Apher Sci; 2016 Oct; 55(2):212-215. PubMed ID: 27377884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morbidly Obese Patient on Rivaroxaban Presents With Recurrent Upper Extremity Deep Vein Thrombosis: A Case Report.
    Jennings ST; Manh KNP; Bita J
    J Pharm Pract; 2020 Oct; 33(5):712-719. PubMed ID: 31232154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appropriateness of Dabigatran and Rivaroxaban Prescribing in Qatar: A 5-Year Experience.
    Elewa H; El-Makaty H; Ali Z
    J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):155-161. PubMed ID: 28978236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral drug therapy following bariatric surgery: an overview of fundamentals, literature and clinical recommendations.
    Azran C; Wolk O; Zur M; Fine-Shamir N; Shaked G; Czeiger D; Sebbag G; Kister O; Langguth P; Dahan A
    Obes Rev; 2016 Nov; 17(11):1050-1066. PubMed ID: 27335140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bariatric surgery for type 2 diabetes: to whom and when?
    Samaras K
    Minerva Endocrinol; 2013 Mar; 38(1):47-58. PubMed ID: 23435442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpatient Variation in Rivaroxaban and Apixaban Plasma Concentrations in Routine Care.
    Gulilat M; Tang A; Gryn SE; Leong-Sit P; Skanes AC; Alfonsi JE; Dresser GK; Henderson SL; Rose RV; Lizotte DJ; Teft WA; Schwarz UI; Tirona RG; Kim RB
    Can J Cardiol; 2017 Aug; 33(8):1036-1043. PubMed ID: 28754389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of bariatric surgery on the use and pharmacokinetics of some major drug classes.
    Yska JP; van der Linde S; Tapper VV; Apers JA; Emous M; Totté ER; Wilffert B; van Roon EN
    Obes Surg; 2013 Jun; 23(6):819-25. PubMed ID: 23430479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evidence summary of the management of patients taking direct oral anticoagulants (DOACs) undergoing dental surgery.
    Johnston S
    Int J Oral Maxillofac Surg; 2016 May; 45(5):618-30. PubMed ID: 26774397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct oral anticoagulants and heparins: laboratory values and pitfalls in 'bridging therapy'.
    Eller T; Flieder T; Fox V; Gripp T; Dittrich M; Kuhn J; Alban S; Knabbe C; Birschmann I
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):624-632. PubMed ID: 28043992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent Rivaroxaban Effect Due to Impaired Renal Clearance and Medication Effects.
    Milito C; McRae H; Victor A; Refaai MA; Schmidt AE
    Lab Med; 2020 Mar; 51(2):211-216. PubMed ID: 31340380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Cross-Study Analysis Evaluating the Effects of Food on the Pharmacokinetics of Rivaroxaban in Clinical Studies.
    Zhang L; Peters G; Haskell L; Patel P; Nandy P; Moore KT
    J Clin Pharmacol; 2017 Dec; 57(12):1607-1615. PubMed ID: 28679020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct oral anticoagulants (DOACs).
    Vazquez S; Rondina MT
    Vasc Med; 2015 Dec; 20(6):575-7. PubMed ID: 26285587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left atrial thrombus and dense spontaneous echocardiographic contrast in patients on continuous direct oral anticoagulant therapy undergoing catheter ablation of atrial fibrillation: Comparison of dabigatran, rivaroxaban, and apixaban.
    Wu M; Gabriels J; Khan M; Shaban N; D'Amato S; Liu CF; Markowitz SM; Ip JE; Thomas G; Singh P; Lerman B; Patel A; Cheung JW
    Heart Rhythm; 2018 Apr; 15(4):496-502. PubMed ID: 29605015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of rivaroxaban after bariatric surgery: a case report.
    Mahlmann A; Gehrisch S; Beyer-Westendorf J
    J Thromb Thrombolysis; 2013 Nov; 36(4):533-5. PubMed ID: 23417780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal dosing of rivaroxaban is undefined.
    Moore TJ
    BMJ; 2016 Oct; 355():i5549. PubMed ID: 27756735
    [No Abstract]   [Full Text] [Related]  

  • 19. Anesthetic drugs and bariatric surgery.
    Lemmens HJ; Brodsky JB
    Expert Rev Neurother; 2006 Jul; 6(7):1107-13. PubMed ID: 16831123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosing of rivaroxaban by indication: getting the right dose for the patient.
    Escolar G; Carne X; Arellano-Rodrigo E
    Expert Opin Drug Metab Toxicol; 2015; 11(10):1665-77. PubMed ID: 26329812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.